The magic pill for the pharma sector
Will the deregulation in drug pricing policy prove to be the long awaited cure for the pharmaceutical industry?
Highnoon Laboratories partners with Bangladesh-based Beximco Pharmaceuticals for strategic collaboration
Both firms sign MoU to distribute and market specialised pharmaceutical products in Pakistan, focusing on key therapeutic areas
Citi Pharma’s veterinary subsidiary begins operations, launching 32 products initially
Citi Veterinary Limited projects a turnover of Rs 1.5 billion for FY 2025-26, with plans to establish Pakistan's first dedicated veterinary Active Pharmaceutical Ingredient (API) plant
Liven Pharmaceuticals just made a rights issue. Will this prove to be the last throw of the dice?
The pharmaceutical company has had a torrid history. The new development could prove to be its redemption
Seasonal flu pushing up rates of Arinac Forte, Panadol CF
KARACHI: As seasonal flu sets in, demand has surged for Arinac Forte and Panadol CF , used for cold and flu and witnessed...
Panadol costs more now. What has this meant for the pharma industry?
Haleon has benefited from the new drug pricing policy introduced by DRAP and it shows in its financial results
Hoechst Pakistan to acquire products and trademarks from Sanofi affiliates
Board approves strategic acquisition to strengthen product portfolio and market position
Citi Pharma ventures into direct marketing sector
Company aims to improve medicine accessibility and expand globally
Saudi investors exit Pakistan’s largest pharmacy chain. What happened and why?
From its origins as part of the Servis Group to multiple changes in ownership since its inception in 2005, Servaid has undergone an eventful two decades in existence
Do cures harm the drug business?
OTTAWA: "Is curing patients a sustainable business model?" That provocative question was posed on page 38 of a Goldman Sachs research report...
Searle Company to divest entire stake in Searle Pakistan Limited
Board approves disposal of 100% shareholding; negotiations for terms underway
Pfizer looks beyond COVID sales with $43b deal for cancer drugmaker Seagen
WASHNGTON: Pfizer Inc on Monday struck a roughly $43 billion deal for Seagen Inc to bulk up its cancer treatments portfolio, as...
Britain nears 500 million pound deal for Sanofi, GSK Covid-19 vaccine
LONDON: Britain is close to agreeing a 500 million pound ($624 million) supply deal with Sanofi and GlaxoSmithKline (GSK) for 60 million...
Where did all the Burnol go?
The household product is missing from pharmacies in Pakistan. But its brand recall still holds
PPMA vs DRAP: Pharma crisis continuesÂ
Unavailability of medicines could inevitably trigger national health emergency